JP2021528459A5 - - Google Patents

Info

Publication number
JP2021528459A5
JP2021528459A5 JP2020572806A JP2020572806A JP2021528459A5 JP 2021528459 A5 JP2021528459 A5 JP 2021528459A5 JP 2020572806 A JP2020572806 A JP 2020572806A JP 2020572806 A JP2020572806 A JP 2020572806A JP 2021528459 A5 JP2021528459 A5 JP 2021528459A5
Authority
JP
Japan
Prior art keywords
total weight
acid
pharmaceutical composition
composition according
mannuron
Prior art date
Application number
JP2020572806A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020001644A5 (https=
JP2021528459A (ja
Filing date
Publication date
Priority claimed from CN201810721304.5A external-priority patent/CN110652526A/zh
Application filed filed Critical
Publication of JP2021528459A publication Critical patent/JP2021528459A/ja
Publication of JP2021528459A5 publication Critical patent/JP2021528459A5/ja
Publication of JPWO2020001644A5 publication Critical patent/JPWO2020001644A5/ja
Pending legal-status Critical Current

Links

JP2020572806A 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528459A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810721304.5 2018-06-29
CN201810721304.5A CN110652526A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗糖尿病中的应用
PCT/CN2019/093822 WO2020001644A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗糖尿病中的应用

Publications (3)

Publication Number Publication Date
JP2021528459A JP2021528459A (ja) 2021-10-21
JP2021528459A5 true JP2021528459A5 (https=) 2022-07-04
JPWO2020001644A5 JPWO2020001644A5 (https=) 2022-07-04

Family

ID=68985883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572806A Pending JP2021528459A (ja) 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406652B2 (https=)
EP (1) EP3815690A4 (https=)
JP (1) JP2021528459A (https=)
KR (1) KR20210038875A (https=)
CN (1) CN110652526A (https=)
AU (1) AU2019296855A1 (https=)
WO (1) WO2020001644A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336742A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN100508985C (zh) * 2004-03-24 2009-07-08 中国海洋大学 褐藻胶寡糖及其衍生物及其制备方法和用途
CN101889027B (zh) 2007-12-29 2013-05-01 于传兴 低分子量海藻酸及其盐、应用、制法及药物组合物、食品
KR20160116252A (ko) 2015-03-27 2016-10-07 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당 및 이를 유효성분으로 포함하는 조성물
PL3498722T3 (pl) * 2016-08-15 2021-09-20 Shanghai Green Valley Pharmaceutical Co., Ltd. Sposób przygotowania oligomerycznego dikwasu mannuronowego
JP6977059B2 (ja) * 2016-12-30 2021-12-08 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. マンヌロン二酸の組成物

Similar Documents

Publication Publication Date Title
CN103830163B (zh) 用于制备阿达帕林凝胶的方法
JP5715400B2 (ja) ロキソプロフェン含有医薬組成物
JP2004526664A (ja) 軟ゼラチン配合物とともに使用される薬学的組成物の調製方法
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
JP5781152B2 (ja) アセトアミノフェン組成物
JP2021528459A5 (https=)
JP2021529195A5 (https=)
JP2005187407A (ja) アレルギー眼疾患用眼科組成物
CN101621997B (zh) 医药组合物
JP2021528460A5 (https=)
EP2814848B1 (en) Partially depolymerized glycosaminoglycan silver and gold salts
JP2001527022A5 (https=)
JP2020011903A (ja) 外用組成物
JP2022125226A (ja) 口腔用組成物の製造方法、口腔用組成物の口腔内塗布部との密着性を向上させる方法および口腔用組成物の口腔内塗布部における滞留性を向上させる方法。
JP2021528458A5 (https=)
JP2003128588A (ja) 多糖類含有組成物およびその用途
CA2711407A1 (en) Aqueous dispersion containing polysaccharide particulate gel and method for producing the same
JPWO2020001644A5 (https=)
JP3472442B2 (ja) 損傷皮膚修復用製剤
ITMI20071120A1 (it) Composizione antiartrosica
JPWO2020001640A5 (https=)
JPWO2020001643A5 (https=)
JP7569059B2 (ja) 皮膚外用剤
JP2021529196A5 (https=)
JP6675397B2 (ja) 眼科用組成物